Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Directors Deals Ltd.
$12.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bukwang Pharm Co Ltd Declares Annual Cash Dividend for FY 2012


Monday, 25 Feb 2013 09:23pm EST 

Bukwang Pharm Co Ltd announced that it has declared an annual cash dividend of KRW 500 per share of common stock to shareholders of record on December 31, 2012, for the fiscal year 2012. The dividend rate of market price is 3.41% and the total amount of the cash dividend is KRW 13,427,212,000. The Company's annual cash dividend for the fiscal year 2011 was KRW 200 per share. 

Latest Developments for Bukwang Pharm Co Ltd

Company Quote

17950.0
300.0 +1.70%
28 Nov 2014